Q2 2015 ... $474,000
Q3 2015 ... $931,000
Q4 2015 ... $1,429,000
Q1 2016 ... $1,941,000
Q2 2016 ... $2,425,000
150 hospitals as of Q1 under old pricing
12 month to change existing hospitals of 150 to the new increased pricing
$25k per hospital spend on new increased pricing.
adding 15 new hospitals a month with 5 sales force and 30 with 10 sales force and 3 months lag from date of hire
Sorry, Q2 recorded a one time $850k on sales of rapid cholesterol to 36S. That item is still in trade receiv.
Ex this item, Q2 2014 was about $500k. $350k of that was Hep allergy HIT test.
Sentiment: Strong Buy
Didn't the VP say, if customer orders high volume, they can get the chip under $6. So, am guessing around $5, as he did not say under $5
Asus targeting 30M smart phone sales this year. Overall, Asus tablet and phone sales for 2016 should well exceed 50M units. In comparison, all of 4k TV sold last year was about 10M
The mobile space is orders of magnitude bigger and pixie chip is, for now, the only one out there saving battery life, cost and better resolution.
This is going higher
True that Q2 2014 (last year quarter) sales were $1.35M. However, much of that were from alcohol breath test )similar to Q1 2014) which no longer exists.
Hep allergy test were about $330k in Q2 2014. The price increase of 2.5 will be phased in over next year, so we should see little impact this quarter.
We should see impact of sales force going from 2 to 5 this quarter. And going from 5 to 10, next quarter. So, a very good scenario is for them doing $500k of rapid Hep allergy test this quarter.
As for other tests, they tend to be lumpy orders of $1M from china or from middle east and they usually announce those. So, am guessing none in Q2.
So, i would consider a $750k revenue in Q2 as very good.
There are just too much going on in this company with explosive revenue potential that I would not worry much about Q2. If they do get to cash break even this year, you are looking at $25 stock. If they turn profit, much higher.
Having said that, your Q2 rev model (or from that analyst) is unrealistic.
goran .. i they get to cash breakeven this year, that would be outstanding and stock will go higher ..
cash breakeven is $7.7M annual revenue or $1.8M per quarter
They did $500k in Q1. I epxect $750k in Q2 wihic is still a 50% QoQ growth
Price increase or Hep HIT test will not take into effect for existing customers till next July
I am interested to see what model you are using that is giving you such lofty expectation for Q2 ..
Good luck to all
it appears very few buyers or sellers ..
i expect Q2 to be modest improvement from Q1 .. but, probably up form here
GL to all longs and those on sideline and those short .. Do your due deligience
It will soon be a must have chip for all vendors (500 million to 1 billion unit sales a year) .. They have to either dev in house, or buy pixi chip .. Most likely (and unfortunately), someone will take them out soon though
So, a rapid test using breath test would be a welcome tool and could catch on very quick as the user base is already there ... how big is the user base?
I have expressed my thoughts in past posts ... What do you think? and why?
problem with TV was that Samsung, Sony and Toshiba which dominate the market also had great in-house tech ..
same can not be said for lenovo, ACER, DELL, HP, APPLE,Xiomi,Asus .. Also, the inhouse tech of toshiba, sony need 1 year of work to get where pxlw is in now with iris chip
to make it more interesting, market for mobil is much larger than 4k tv
so, stay long on this one
once asus puts in, others will follow
why rb4 sells better in xb1 than ps4?
think about it ... only two options -- either CR increase or a big pocket player will take them out by earnings date ... RB 4 is bigger than measly market cap here
interesting that guitar only has no interest ... Also, Fallout is only pre-order to be notifed .. So, technically, it is #1 (whatever that means!)
And, If the chip is good, then this is just scratching the surface .. 2016 and 2017 you could see orders of magnitude higher ...